Chiropractic Offers Long Term Benefits for Fibromyalgia Sufferers

If you are struggling with fibromyalgia, you are not alone, as Gadsden Family Chiropractic sees many people with this particular problem in our Gadsden, AL chiropractic clinic. In fact, the Centers for Disease Control and Prevention (CDC) reports that roughly two percent of all adults in the US have fibromyalgia. Thankfully, chiropractic is one treatment option that can provide positive results.

Research Shows Chiropractic Eases Fibromyalgia

In a medical study published in mid-2015, 215 adults with fibromyalgia were evaluated based on factors ranging from pain to quality of sleep to the levels of depression symptoms or anxiety they felt. Then they were divided into two groups with one group receiving a multi-modal therapy program for three months and the second group receiving the same program with the addition of chiropractic adjustments (specifically, to the upper neck tissues) for the same length of time.

The subjects who received chiropractic care in conjunction with the multi-disciplinary treatment approach reported greater results in all areas (pain, sleep, depression, and anxiety) at three months post-treatment when compared to the study participants who received multi-modal treatment without chiropractic care. Additionally, those positive results were long-lasting as the patients reported continued improvement one full year later.

Fibromyalgia can greatly decrease your quality of life, both psychologically and physically. If you're suffering from fibromyalgia, we might be able to help.

You don't have to suffer! To find out what Gadsden Family Chiropractic can do for your fibromyalgia pain, call our Gadsden, AL chiropractic office today.

Research

• Fibromyalgia. Centers for Disease Control and Prevention. Retrieved from http://www.cdc.gov/arthritis/basics/fibromyalgia.htm on November 2, 2015.
• Moustafa I & Diab A. (2015, July). The addition of upper cervical manipulative therapy in the treatment of patients with fibromyalgia: a randomized controlled trial. Rheumatology International;35(7):1163-74.